Fibrinolysis: an illustrated review

Area of Science:

• Biochemistry
• Physiology
• Hematology

Background:

• Hemostasis forms blood clots to stop bleeding after vessel injury.
• Clot resolution, or fibrinolysis, is essential for wound healing and preventing pathological thrombosis.
• Fibrin is the primary structural component of blood clots, encasing cellular elements.

Purpose of the Study:

• To review the process of fibrinolysis, the enzymatic degradation of fibrin clots.
• To explore the regulation of fibrinolysis by activators and inhibitors.
• To discuss the influence of clot structure on lysis rates and advancements in thrombolytic agents.

Main Methods:

• Literature review of fibrinolysis and clot structure.
• Analysis of regulatory mechanisms involving plasminogen activators and inhibitors.
• Examination of the impact of fibrin fiber structure and clot contraction on lysis.

Main Results:

• Fibrinolysis involves the proteolytic breakdown of the fibrin network by plasmin.
• Plasminogen activators (t-PA, u-PA) and inhibitors (PAIs, α2-AP, TAFI) tightly regulate fibrinolysis.
• Clot structure, including fibrin fiber thickness and clot contraction, significantly affects lysis speed.

Conclusions:

• Fibrinolysis is a complex, tightly regulated process vital for cardiovascular health.
• Understanding clot structure-function relationships can guide the development of improved thrombolytic therapies.
• Further research is needed to address knowledge gaps and refine therapeutic strategies for thrombotic disorders.